Biliary Atresia

  • Mark Davenport


The first clear documented case of biliary atresia in English was reported in 1891 by the Edinburgh physician John Thompson. The child was jaundiced and was noted to have clay-coloured stool and dark urine throughout and ultimately died from liver failure or sepsis at a few months of age. The post-mortem drawings showed a normally formed but empty gallbladder two small bile filled cysts in the porta hepatis and an absence of the common hepatic duct.


Biliary atresia Classification Aetiology and pathogenesis Portoenterostomy Variant anomalies Outcomes 


  1. 1.
    Thomson J. On congenital obliteration of the bile ducts. Edinb Med J. 1891;37:523–31.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Ladd WE. Congenital atresia and stenosis of the bile ducts. JAMA. 1928;91:1082–5.CrossRefGoogle Scholar
  3. 3.
    Kasai M, Suzuki S. A new operation for “non-correctable” biliary atresia—portoenterostomy. Shijitsu. 1959;13:733–9.Google Scholar
  4. 4.
    Starzl TM, Marchioro TL, Von Kaulia KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–76.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704–13.CrossRefGoogle Scholar
  6. 6.
    Caponcelli E, Knisely AS, Davenport M. Cystic biliary atresia: an etiologic and prognostic subgroup. J Pediatr Surg. 2008;43:1619–24.CrossRefGoogle Scholar
  7. 7.
    Davenport M, Savage M, Mowat AP, Howard ER. The biliary atresia splenic malformation syndrome. Surgery. 1993;113:662–8.Google Scholar
  8. 8.
    Davenport M, Tizzard SA, Underhill J, Mieli-Vergani G, Portmann B, Hadzić N. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr. 2006;149:393–400.CrossRefGoogle Scholar
  9. 9.
    Zani A, Quaglia A, Hadzic N, Zuckerman M, Davenport M. Cytomegalovirus-associated biliary atresia: an aetiological and prognostic subgroup. J Pediatr Surg. 2015;50:1739–45.CrossRefGoogle Scholar
  10. 10.
    Allotey J, Lacaille F, Lees MM, Strautnieks S, Thompson RJ, Davenport M. Congenital bile duct anomalies (biliary atresia) and chromosome 22 aneuploidy. J Pediatr Surg. 2008;43:1736–40.CrossRefGoogle Scholar
  11. 11.
    Livesey E, Cortina Borja M, Sharif K, Alizai N, McClean P, Kelly D, Hadzic N, Davenport M. Epidemiology of biliary atresia in England and Wales (1999–2006). Arch Dis Child Fetal Neonatal Ed. 2009;94:F451–5.CrossRefGoogle Scholar
  12. 12.
    Kohsaka T, Yuan ZR, Guo SX, et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology. 2002;36:904–12.CrossRefGoogle Scholar
  13. 13.
    Shimadera S, Iwai N, Deguchi E, Kimura O, Fumino S, Yokoyama T. The inv mouse as an experimental model of biliary atresia. J Pediatr Surg. 2007;42:1555–60.CrossRefGoogle Scholar
  14. 14.
    Davit-Spraul A, Baussan C, Hermeziu B, Bernard O, Jacquemin E. CFC1 gene involvement in biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr. 2008;46:111–2.CrossRefGoogle Scholar
  15. 15.
    Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med. 1997;181:33–40.CrossRefGoogle Scholar
  16. 16.
    Davenport M, Gonde C, Redkar R, Koukoulis G, Tredger M, Mieli-Vergani G, Portmann B, Howard ER. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg. 2001;36:1017–25.CrossRefGoogle Scholar
  17. 17.
    Mack CL, Falta MT, Sullivan AK, Karrer F, Sokol RJ, Freed BM, Fontenot AP. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology. 2007;133:278–87.CrossRefGoogle Scholar
  18. 18.
    Ahmed AF, Ohtani H, Nio M, et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Pathol. 2001;193:383–9.CrossRefGoogle Scholar
  19. 19.
    Harada K, Nakanuma Y. Biliary innate immunity: function and modulation. Mediators Inflamm 2010;2010. pii: 373878. Epub 2010 Jul 27.Google Scholar
  20. 20.
    Hill R, Quaglia A, Hussain M, Hadzic N, Mieli-Vergani G, Vergani D, et al. Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg. 2015;50:1297–303.CrossRefGoogle Scholar
  21. 21.
    Tucker RM, Feldman AG, Fenner EK, Mack CL. Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia. J Hepatol. 2013;59:790–6.CrossRefGoogle Scholar
  22. 22.
    Lages CS, Simmons J, Chougnet CA, Miethke AG. Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia. Hepatology. 2012;56:219–27.CrossRefGoogle Scholar
  23. 23.
    Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology. 2012;55:1130–8.CrossRefGoogle Scholar
  24. 24.
    Minnick KE, Kreisberg R, Dillon PW. Soluble ICAM-1 (sICAM-1) in biliary atresia and its relationship to disease activity. J Surg Res. 1998;76:53–6.CrossRefGoogle Scholar
  25. 25.
    Davenport M, Gonde C, Narayanaswamy B, Mieli-Vergani G, Tredger JM. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J Pediatr Surg. 2005;40:1464–9.CrossRefGoogle Scholar
  26. 26.
    Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M. Serial circulating markers of inflammation in biliary atresia—evolution of the post-operative inflammatory process. Hepatology. 2007;46:180–7.CrossRefGoogle Scholar
  27. 27.
    Tracy TF, Dillon P, Fox ES, et al. The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J Pediatr Surg. 1996;31:121–5.CrossRefGoogle Scholar
  28. 28.
    Kobayashi H, Puri P, O’Briain S, et al. Hepatic overexpression of MHC Class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg. 1997;32:596–3.Google Scholar
  29. 29.
    Petersen C, Biermanns D, Kuske M, Schäkel K, Meyer-Junghänel L, Mildenberger H. New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg. 1997;32:1190–5.CrossRefGoogle Scholar
  30. 30.
    Turowski C, Leonhardt J, Teichmann B, Heim A, Baumann U, Kuebler JF, Petersen C. Preconceptional oral vaccination prevents experimental biliary atresia in newborn mice. Eur J Pediatr Surg. 2010;20:158–63.CrossRefGoogle Scholar
  31. 31.
    Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1982;307:481–4.CrossRefGoogle Scholar
  32. 32.
    Rauschenfels S, Krassmann M, Al-Masri AN, Verhagen W, Leonhardt J, Kuebler JF, Petersen C. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr. 2009;168:469–76.CrossRefGoogle Scholar
  33. 33.
    Miethke AG, Saxena V, Shivakumar P, Sabla GE, Simmons J, Chougnet CA. Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol. 2010;52:718–26.CrossRefGoogle Scholar
  34. 34.
    Shivakumar P, Sabla G, Mohanty S, McNeal M, Ward R, Stringer K, Caldwell C, Chougnet C, Bezerra JA. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology. 2007;133:268–77.CrossRefGoogle Scholar
  35. 35.
    Mack CL, Tucker RM, Lu BR, et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology. 2006;44:1231–9.CrossRefGoogle Scholar
  36. 36.
    Harada K, Sato Y, Itatsu K, et al. Innate immune response to double stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology. 2007;46:1146–54.CrossRefGoogle Scholar
  37. 37.
    Lu BR, Brindley SM, Tucker RM, Lambert CL, Mack CL. α-Enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology. 2010;139:1753–61.CrossRefGoogle Scholar
  38. 38.
    Davenport M. Biliary atresia: from Australia to the zebrafish. J Pediatr Surg. 2016;51:200–5.CrossRefGoogle Scholar
  39. 39.
    Harpavat S, Finegold MJ, Karpen SJ. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics. 2011;128:e1428–33.CrossRefGoogle Scholar
  40. 40.
    Ng J, Paul A, Wright N, Hadzic N, Davenport M. Vitamin D Levels in infants with biliary atresia: pre and post Kasai portoenterostomy. J Pediatr Gastroenterol Nutr 2016. ;62(5):746–50. [Epub ahead of print].CrossRefGoogle Scholar
  41. 41.
    Hinds R, Davenport M, Mieli-Vergani G, Hadzic N. Antenatal presentation of biliary atresia. J Pediatr. 2004;144:43–6.CrossRefGoogle Scholar
  42. 42.
    Makin E, Quaglia A, Kvist N, Petersen BL, Portmann B, Davenport M. Congenital biliary atresia: liver injury begins at birth. J Pediatr Surg. 2009;44:630–3.CrossRefGoogle Scholar
  43. 43.
    Davenport M, Betalli P, D’Antiga L, et al. The spectrum of surgical jaundice in infancy. J Pediatr Surg. 2003;38:1471–9.CrossRefGoogle Scholar
  44. 44.
    Park WH, Choi SO, Lee HJ, et al. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Pediatr Surg. 1997;32:1555–9.CrossRefGoogle Scholar
  45. 45.
    Humphrey TM, Stringer MD. Biliary atresia: US diagnosis. Radiology. 2007;244:845–51.CrossRefGoogle Scholar
  46. 46.
    Shanmugam NP, Harrison PM, Devlin J, Peddu P, Knisely AS, Davenport M, Hadzić N. Selective use of endoscopic retrograde cholangiopancreatography in the diagnosis of biliary atresia in infants younger than 100 days. J Pediatr Gastroenterol Nutr. 2009;49:435–41.CrossRefGoogle Scholar
  47. 47.
    Nose S, Hasegawa T, Soh H, Sasaki T, Kimura T, Fukuzawa M. Laparoscopic cholecystocholangiography as an effective alternative exploratory laparotomy for the differentiation of biliary atresia. Surg Today. 2005;35:925–8.CrossRefGoogle Scholar
  48. 48.
    Hsiao CH, Chang MH, Chen HL, Lee HC, Wu TC, Lin CC, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology. 2008;47:1233–40.CrossRefGoogle Scholar
  49. 49.
    Zhao R, Li H, Shen C, Zheng S, Xiao X. Hepatic portocholecystostomy (HPC) is ineffective in the treatment of biliary atresia with patent distal extrahepatic bile ducts. J Investig Surg. 2011;24:53–8.CrossRefGoogle Scholar
  50. 50.
    Dutta S, Woo R, Albanese CT. Minimal access portoenterostomy: advantages and disadvantages of standard laparoscopic and robotic techniques. J Laparoendosc Adv Surg Tech A. 2007;17:258–64.CrossRefGoogle Scholar
  51. 51.
    Wong KK, Chung PH, Chan KL, Fan ST, Tam PK. Should open Kasai portoenterostomy be performed for biliary atresia in the era of laparoscopy? Pediatr Surg Int. 2008;24:931–3.CrossRefGoogle Scholar
  52. 52.
    Ure BM, Kuebler JF, Schukfeh N, Engelmann C, Dingemann J, Petersen C. Survival with the native liver after laparoscopic versus conventional Kasai portoenterostomy in infants with biliary atresia: a prospective trial. Ann Surg. 2011;253:826–30.CrossRefGoogle Scholar
  53. 53.
    Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER. Biliary atresia: the King’s College Hospital experience (1974–1995). J Pediatr Surg. 1997;32:479–85.CrossRefGoogle Scholar
  54. 54.
    Superina R, Magee JC, Brandt ML, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg. 2011;254:577–85.CrossRefGoogle Scholar
  55. 55.
    Meyers RL, Book LS, O’Gorman M, et al. High dose steroids, ursodeoxycholic acid and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg. 2004;38:406–11.CrossRefGoogle Scholar
  56. 56.
    Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T, Urao M, et al. Optimum prednisolone usage in patients with biliary atresia post-portoenterostomy. J Pediatr Surg. 2005;40:327–30.CrossRefGoogle Scholar
  57. 57.
    Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007; 46: 1821–7.Google Scholar
  58. 58.
    Davenport M, Parsons C, Tizzard S, Hadzic N. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol. 2013;59:1054–8.CrossRefGoogle Scholar
  59. 59.
    Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311:1750–9.CrossRefGoogle Scholar
  60. 60.
    Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y. Postoperative steroid therapy for biliary atresia: systematic review and meta-analysis. J Pediatr Surg. 2015;50:1590–4.CrossRefGoogle Scholar
  61. 61.
    Willot S, Uhlen S, Michaud L, et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics. 2008;122:e1236–41.CrossRefGoogle Scholar
  62. 62.
    Ecoffey C, Rothman E, Bernard O. Bacterial cholangitis after surgery for biliary atresia. J Pediatr. 1987;111:824–9.CrossRefGoogle Scholar
  63. 63.
    Rothenberg SS, Schroter GP, Karrer FM, Lilly JR. Cholangitis after the Kasai operation for biliary atresia. J Pediatr Surg. 1989;24:729–32.CrossRefGoogle Scholar
  64. 64.
    Shalaby A, Makin E, Davenport M. Portal venous pressure in biliary atresia. J Pediatr Surg. 2012;47:363–6.CrossRefGoogle Scholar
  65. 65.
    Kang N, Davenport M, Driver M, Howard ER. Hepatic histology and the development of esophageal varices in biliary atresia. J Pediatr Surg. 1993;28:63–6.CrossRefGoogle Scholar
  66. 66.
    Stringer MD, Howard ER, Mowat AP. Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia. J Pediatr Surg. 1989;24:438–42.CrossRefGoogle Scholar
  67. 67.
    Duché M, Ducot B, Tournay E, et al. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology. 2010;139:1952–60.CrossRefGoogle Scholar
  68. 68.
    Eroglu Y, Emerick KM, Whitington PF, Alonso EM. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr. 2004;38:41–7.CrossRefGoogle Scholar
  69. 69.
    Davenport M, Ong E, Sharif K, et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg. 2011;46:1689–94.CrossRefGoogle Scholar
  70. 70.
    Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K. Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg. 2003;38:997–1000.CrossRefGoogle Scholar
  71. 71.
    Serinet MO, Broué P, Jacquemin E, Lachaux A, Sarles J, Gottrand F, et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986–2002. Hepatology. 2006;44:75–84.CrossRefGoogle Scholar
  72. 72.
    Wildhaber BE, Majno P, Mayr J, Zachariou Z, Hohlfeld J, Schwoebel M, et al. Biliary atresia: Swiss national study, 1994–2004. J Pediatr Gastroenterol Nutr. 2008;46:299–307.CrossRefGoogle Scholar
  73. 73.
    Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151:659–65.CrossRefGoogle Scholar
  74. 74.
    Davenport M, Caponcelli E, Livesey E, Hadzic N, Howard E. Surgical outcome in biliary atresia: etiology affects the influence of age at surgery. Ann Surg. 2008;247:694–8.CrossRefGoogle Scholar
  75. 75.
    McClement JW, Howard ER, Mowat AP. Results of surgical treatment for extrahepatic biliary atresia in United Kingdom 1980–2. Br Med J. 1985;290:345–7.CrossRefGoogle Scholar
  76. 76.
    McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet. 2000;355:25–9.CrossRefGoogle Scholar
  77. 77.
    Kvist N, Davenport M. Thirty-four years’ experience with biliary atresia in Denmark: a single center study. Eur J Pediatr Surg. 2011;21:224–8.CrossRefGoogle Scholar
  78. 78.
    Lampela H, Ritvanen A, Kosola S, et al. National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scand J Gastroenterol. 2012;47:99–107.CrossRefGoogle Scholar
  79. 79.
    Davenport M, Howard ER. Macroscopic appearance at portoenterostomy—a prognostic variable in biliary atresia. J Pediatr Surg. 1996;31:1387–90.CrossRefGoogle Scholar
  80. 80.
    Howard ER, Driver M, McClement J, Mowat AP. Results of surgery in 88 consecutive cases of extrahepatic biliary atresia. J R Soc Med. 1982;75:408–13.PubMedPubMedCentralGoogle Scholar
  81. 81.
    Tan CE, Davenport M, Driver M, Howard ER. Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg. 1994;29:1459–64.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Paediatric SurgeryKing’s College HospitalLondonUK

Personalised recommendations